Gujarat sits at number one in India for pharmaceutical manufacturing, and it isn’t particularly close. The state pushes out 33% of the country’s entire drug supply, keeps 3,500 manufacturing units running, has 130 USFDA-certified facilities under its belt, and is where households names like Zydus Lifesciences, Sun Pharma, Torrent Pharmaceuticals, Alembic Pharmaceuticals from Vadodara, Intas Pharmaceuticals, Cadila Pharmaceuticals, and Amneal Pharmaceuticals have all put down roots. Ahmedabad and Vadodara are the two cities that the whole pharma ecosystem in the state essentially revolves around.
But here’s the thing, with that sheer volume of pharmaceutical production sitting right there in Gujarat, companies have spent years having to box up samples and send them off to Mumbai, Pune, or Hyderabad every single time advanced material characterisation testing came up, which meant waiting weeks for results to come back and dealing with the kind of coordination back-and-forth that adds nothing but friction and delay. Head here to read how Pharmaceutical Material Characterisation at MNRDC evolves and thrives at all levels!
What Pharma Companies Actually Need from a Testing Lab
Polymorph Screening (XRD)
The Bruker D6 PHASER XRD at MNRDC identifies crystal phases using Bragg’s Law diffraction and matches results against the ICDD PDF-4 database (one million+ reference patterns). TOPAS Rietveld refinement quantifies the exact proportion of each polymorph in a multi-phase sample, which is the publication and regulatory standard.
Particle Morphology and Size (SEM+EDS)
The Hitachi SU3800 SEM at MNRDC images particles at nanometre resolution (897+ samples analysed to date). EDS simultaneously confirms elemental composition, verifying API purity and detecting trace contaminants or unexpected elements that could indicate raw material quality issues.
Tablet Coating Roughness (AFM)
Drug dissolution rate is influenced by tablet coating uniformity. The Nanosurf Core AFM measures surface roughness at the nanoscale (Sa, Sq, Sz parameters via MountainsSPIP), confirming whether a tablet coating meets the smoothness specification required for controlled drug release. Roughness data is delivered as an Excel sheet with 50+ ISO S-parameters.
Existing Pharma Clients at MNRDC
MNRDC already serves pharmaceutical companies from Gujarat and beyond. Confirmed pharma-sector clients include BDR Pharmaceuticals International Pvt. Ltd., BDR Lifescience Pvt. Ltd., AMI Lifesciences Pvt. Ltd., Nomisma Healthcare Pvt. Ltd., and Aamyo Laboratories Pvt. Ltd. The center’s 60% repeat client rate reflects the operational reliability that pharmaceutical quality control demands: consistent methodology, predictable turnaround, and confidential handling of proprietary formulation data.
Why Test Locally Instead of Sending to Mumbai
- Turnaround: 10 working days at MNRDC vs up to 3 months at fragmented external facilities
- Iteration: if XRD shows an unexpected polymorph, SEM follow-up can be done immediately at the same facility
- Confidentiality: NDAs available for proprietary API compositions and formulation data
- Single invoice: one submission point, one queue, one payment instead of coordinating across multiple labs
- Proximity: Vadodara is within 110 km of Ahmedabad (Gujarat’s pharma capital), accessible in under 2 hours
FAQ
Can MNRDC do XRD polymorph screening for pharma?
Yes. Bruker D6 PHASER with ICDD PDF-4 database (one million+ reference patterns) and TOPAS Rietveld refinement for quantitative phase analysis. CuK-alpha source, LYNXEYE XE-T detector, standard 10-80 degree range. 600+ samples analysed. Per-sample pricing with NDA available.
Which pharma companies already use MNRDC?
Confirmed clients include BDR Pharmaceuticals, BDR Lifescience, AMI Lifesciences, Nomisma Healthcare, and Aamyo Laboratories. 60% of MNRDC users are repeat clients.
